Name: Latest research reports of Divi's Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: Motilal Oswal

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	08 Sep 2025	Divi's Laboratories	Consensus Share Price Target	6001.50	6362.79	-	6.02	hold	pdf Detailed Estimates
	06 Nov 2023	Divi's Laboratories	Motilal Oswal Target	6001.50	3330.00	3506.70 (71.14%)	Target met	Neutral	pdf post cache	Broker Report Pricing pressure in API segment hurts profitability Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2023	Divi's Laboratories	ICICI Securities Limited Target	6001.50	3680.00	3730.55 (60.87%)	Target met	Hold	pdf post cache	Broker Report Margins at inflection, outlook improving ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q1FY24 revenue growth was impacted by severe pricing pressure in Europe though EBITDA margin at 28.3% was broadly in line with the guidance of a sequential recovery. Raw material cost (down 373bps QoQ) has also started softening now. pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2023	Divi's Laboratories	Prabhudas Lilladhar Reco Target	6001.50	3000.00	3730.55 (60.87%)		Sell	pdf post cache	Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2023	Divi's Laboratories	Motilal Oswal Target	6001.50	3430.00	3730.55 (60.87%)	Target met	Neutral	pdf post cache	Broker Report Margin recovers; sales yet to pick up Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2023	Divi's Laboratories	Geojit BNP Paribas Target	6001.50	3783.00	3383.15 (77.39%)	Target met	Buy	pdf post cache	Broker Report DIVI' S LAB Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	23 May 2023	Divi's Laboratories	SMC online	6001.50		3385.80 (77.26%)		Results Update	pdf post cache	Broker Report Divis Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	22 May 2023	Divi's Laboratories	ICICI Securities Limited Target	6001.50	3560.00	3265.00 (83.81%)	Target met	Accumulate	pdf post cache	Broker Report Pricey RM dampens margins; outlook improving ICICI Securities Limited Divi’s Laboratories’ (Divi’s) has posted its highest ever quarterly sales in generics segment of Rs10bn, up 42% YoY in Q4FY23, though a surge in raw material price and overhead cost has impacted margins (down 1,670bps YoY). Management has indicated a gradual improvement in margins Q1FY24 onwards as it has exhausted high-priced inventory and raw material prices are also declining. pdf Copy Link Share on Share on Share on Share on Alert
	22 May 2023	Divi's Laboratories	Motilal Oswal Target	6001.50	2900.00	3265.00 (83.81%)		Neutral	pdf post cache	Broker Report Healthy pick-up in API sales drives earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	21 May 2023	Divi's Laboratories	Prabhudas Lilladhar	6001.50	2700.00	3098.30 (93.70%)		Hold	pdf post cache	Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	21 May 2023	Divi's Laboratories	ICICI Direct Reco Target	6001.50	3575.00	3098.30 (93.70%)	Target met	Buy	pdf post cache	Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
more loading

Divi's Laboratories Ltd. share price target

Divi's Laboratories Ltd. has an average share price target of 6414.33. The consensus estimate represents an upside of 6.88% from the last price of 6001.50. View 9 reports from 6 analysts offering long-term price targets for Divi's Laboratories Ltd..

Pricing pressure in API segment hurts profitability

Margins at inflection, outlook improving

DIVI'S LABORATORIES

Margin recovers; sales yet to pick up

DIVI' S LAB

Divis Laboratories

Pricey RM dampens margins; outlook improving

Healthy pick-up in API sales drives earnings

DIVI'S LABORATORIES

Divi's Laboratories

Advisor Screeners